Disruption of the transcription factors MafB and c-Maf in KCs by this approach can overcome tumor-induced KC loss and dysfunction and elicit unprecedented therapeutic effects against various types of metastatic liver cancer. The gene discussed is MAF; the disease is neoplasm.